Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Willow Biosciences Inc T.WLLW

Alternate Symbol(s):  CANSF

Consumer Cyclical Healthcare Technology Advertising Agencies Biotechnology Software - Application Cannabis
Willow Biosciences Inc. is a Canada-based biotechnology company. The Company develops and produces precision fermented functional ingredients for the health and wellness, food and beverage and personal care markets. Its FutureGrown biotechnology platform allows production with sustainability at its core. Its commercial product, Cannabigerol CBG, which is a cannabinoid that has anti-microbial... see more

Recent & Breaking News (TSX:WLLW)

Willow Biosciences Receives Conditional Approval to List on the Toronto Stock Exchange

PR Newswire November 25, 2019

Willow Biosciences Reports Third Quarter 2019 Results and Provides Operations Update

Canada NewsWire November 21, 2019

Willow Biosciences to Participate in Cowen 2nd Annual Boston Cannabis Conference

PR Newswire November 7, 2019

Willow Biosciences to Commence Trading on the OTCQB® Venture Market

Canada NewsWire November 5, 2019

Willow Biosciences to Participate at the Eight Capital & Cassels Brock Global Cannabis Conference

Canada NewsWire September 17, 2019

Willow Biosciences Announces Stock Option Grant and Issuance of Units

Canada NewsWire September 9, 2019

Willow Biosciences Announces Engagement of The Howard Group and Upcoming Presentation at the 8th Annual Gateway Conference on September 5, 2019

Canada NewsWire September 3, 2019

Willow Biosciences Reports Second Quarter 2019 Results and Provides Operations Update

Canada NewsWire August 30, 2019

Synthetic Cannabinoids: The New Age of Medical Marijuana-- CFN Media

Newsfile July 22, 2019

Willow Biosciences Comments on Share Price Activity

Canada NewsWire July 11, 2019

Betting Big on the New Age of Synthetic Cannabinoids - CFN Media

Newsfile June 18, 2019

InvestmentPitch Media Video Discusses Willow Biosciences' Joint Development Agreement with Noramco to Develop Yeast-Based Biosynthesis Platform for Production and Distribution of CBD - Video Available on Investmentpitch.com

Newsfile June 5, 2019

Willow Biosciences and Noramco Announce Joint Development of Biosynthesis Platform for Cannabidiol

Canada NewsWire June 4, 2019

Willow Biosciences: The Science of Industrial Scale Pharmaceutical Cannabinoid Production -- CFN Media

Newsfile May 30, 2019

Willow Biosciences and Tuatara Capital Announce Exercise of Warrants

Canada NewsWire May 27, 2019

Makena Resources Inc., Biocan Technologies Inc. and Epimeron Inc. Announce Completion of Private Placement, Strategic Investment From Tuatara Capital and Business Combination to Form Willow Biosciences Inc.

Canada NewsWire April 12, 2019

Makena Resources Inc., Biocan Technologies Inc. and Epimeron Inc. Provide an Update in Respect of Business Combination to Form Willow Biosciences Inc.

GlobeNewswire April 5, 2019

IIROC Trading Halt - MKNA

Canada NewsWire March 22, 2019

Makena Resources Inc. Announces Execution of Definitive Agreement in Respect of Business Combination With BioCan Technologies Inc. and Epimeron Inc. to Form Willow Biosciences Inc.

GlobeNewswire March 22, 2019

Makena Resources Inc. Announces Increase to Previously Announced Private Placement, Strategic Investment from Tuatara Capital, Update in Respect of Business Combination with Biocan Technologies Inc. and Epimeron Inc.to form Willow Biosciences Inc. and Dis

Canada NewsWire March 12, 2019